Cytotoxic T Cells Mediate Pathology and Metastasis in Cutaneous Leishmaniasis

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Novais, Fernanda O ^a   Carvalho, Lucas P ^b   Graff, Joel W ^c   Beiting, Daniel P ^a   Ruthel, Gordon ^a   Roos, David S ^a   Betts, Michael R ^d   Goldschmidt, Michael H ^a   Wilson, Mary E ^c   de Oliveira, Camila I ^e   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 17; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PERFORIN; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; LEISHMANIA BRAZILIENSIS; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE LOAD; SKIN BIOPSY; SKIN LEISHMANIASIS;

EID: 84884810689     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003504     Document Type: Article

References (59)

1. Jordan KA, Hunter CA, (2010) Regulation of CD8+ T cell responses to infection with parasitic protozoa. Experimental parasitology 126: 318-325.
2. Gunderson AJ, Mohammed J, Horvath FJ, Podolsky MA, Anderson CR, et al. (2012) CD8(+) T Cells Mediate RAS-Induced Psoriasis-Like Skin Inflammation through IFN-gamma. The Journal of investigative dermatology.
3. Ortega C, Fernandez AS, Carrillo JM, Romero P, Molina IJ, et al. (2009) IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. Journal of leukocyte biology 86: 435-443.
4. Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, et al. (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PloS one 5: e14108.
5. Gebhard JR, Perry CM, Harkins S, Lane T, Mena I, et al. (1998) Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. The American journal of pathology 153: 417-428.
6. Haque A, Best SE, Unosson K, Amante FH, de Labastida F, et al. (2011) Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. Journal of immunology 186: 6148-6156.
7. Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, et al. (2003) Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis. Journal of immunology 170: 2221-2228.
8. Silverio JC, Pereira IR, Cipitelli Mda C, Vinagre NF, Rodrigues MM, et al. (2012) CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS pathogens 8: e1002645.
9. Kaye P, Scott P, (2011) Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9: 604-615.
10. Sacks D, Noben-Trauth N, (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nature reviews Immunology 2: 845-858.
11. Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, et al. (2002) CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. Journal of immunology 168: 3992-4000.
12. Uzonna JE, Joyce KL, Scott P, (2004) Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. The Journal of experimental medicine 199: 1559-1566.
13. Novoa R, Bacellar O, Nascimento M, Cardoso TM, Ramasawmy R, et al. (2011) IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection. Parasite immunology 33: 132-136.
14. Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, et al. (2005) Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infection and immunity 73: 7853-7859.
15. Faria DR, Souza PE, Duraes FV, Carvalho EM, Gollob KJ, et al. (2009) Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite immunology 31: 432-439.
16. de Oliveira CI, Brodskyn CI, (2012) The immunobiology of Leishmania braziliensis infection. Frontiers in immunology 3: 145.
17. Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M, (1997) Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis. Journal of immunology 159: 4467-4473.
18. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, et al. (2001) Unlocking the secrets of cytotoxic granule proteins. Journal of leukocyte biology 70: 18-29.
19. Hung JH, Yang TH, Hu Z, Weng Z, DeLisi C, (2012) Gene set enrichment analysis: performance evaluation and usage guidelines. Briefings in bioinformatics 13: 281-291.
20. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. Journal of immunological methods 281: 65-78.
21. de Moura TR, Novais FO, Oliveira F, Clarencio J, Noronha A, et al. (2005) Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infection and immunity 73: 5827-5834.
22. Soong L, Chang CH, Sun J, Longley BJ Jr, Ruddle NH, et al. (1997) Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol 158: 5374-5383.
23. Kono H, Rock KL, (2008) How dying cells alert the immune system to danger. Nature reviews Immunology 8: 279-289.
24. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comparative immunology, microbiology and infectious diseases 27: 305-318.
25. Muller I, Pedrazzini T, Kropf P, Louis J, Milon G, (1991) Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells. International immunology 3: 587-597.
26. Stager S, Rafati S, (2012) CD8(+) T cells in leishmania infections: friends or foes? Front Immunol 3: 5.
27. Gurunathan S, Sacks DL, Brown DR, Reiner SL, Charest H, et al. (1997) Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med 186: 1137-1147.
28. Maroof A, Brown N, Smith B, Hodgkinson MR, Maxwell A, et al. (2012) Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. The Journal of infectious diseases 205: 853-863.
29. Jayakumar A, Castilho TM, Park E, Goldsmith-Pestana K, Blackwell JM, et al. (2011) TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia). PLoS neglected tropical diseases 5: e1204.
30. Kronenberg K, Brosch S, Butsch F, Tada Y, Shibagaki N, et al. (2010) Vaccination with TAT-antigen fusion protein induces protective, CD8(+) T cell-mediated immunity against Leishmania major. The Journal of investigative dermatology 130: 2602-2610.
31. Sanchez-Sampedro L, Gomez CE, Mejias-Perez E, Sorzano CO, Esteban M, (2012) High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection. PloS one 7: e38859.
32. Rocha FJ, Schleicher U, Mattner J, Alber G, Bogdan C, (2007) Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infection and immunity 75: 3823-3832.
33. Silva C, Boaventura VS, Cardoso CR, Tavares NM, Lordelo MJ, et al. (2013) CD8+ Granzyme B+ T cells-mediated tissue injury versus CD4+ IFN-g+ T cells-mediated parasite killing in human cutaneous leishmaniasis. Journal of Investigative Dermatology In press.
34. Tsagozis P, Karagouni E, Dotsika E, (2003) CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis. Parasite immunology 25: 569-579.
35. Soudja SM, Ruiz AL, Marie JC, Lauvau G, (2012) Inflammatory Monocytes Activate Memory CD8(+) T and Innate NK Lymphocytes Independent of Cognate Antigen during Microbial Pathogen Invasion. Immunity 37: 549-562.
36. Barral-Netto M, Barral A, Brodskyn C, Carvalho EM, Reed SG, (1995) Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol 17: 21-28.
37. Kima PE, Ruddle NH, McMahon-Pratt D, (1997) Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells. Journal of immunology 159: 1828-1834.
38. Pinelli E, Gonzalo RM, Boog CJ, Rutten VP, Gebhard D, et al. (1995) Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. European journal of immunology 25: 1594-1600.
39. Russo DM, Chakrabarti P, Higgins AY, (1999) Leishmania: naive human T cells sensitized with promastigote antigen and IL-12 develop into potent Th1 and CD8(+) cytotoxic effectors. Experimental parasitology 93: 161-170.
40. Smith LE, Rodrigues M, Russell DG, (1991) The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages. The Journal of experimental medicine 174: 499-505.
41. Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, et al. (2006) Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141.
42. Winau F, Weber S, Sad S, de Diego J, Hoops SL, et al. (2006) Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24: 105-117.
43. Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C, (2008) NKG2D ligands: key targets of the immune response. Trends in immunology 29: 397-403.
44. Tarleton RL, Koller BH, Latour A, Postan M, (1992) Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-340.
45. Polley R, Stager S, Prickett S, Maroof A, Zubairi S, et al. (2006) Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infection and immunity 74: 773-776.
46. Kaye PM, Cooke A, Lund T, Wattie M, Blackwell JM, (1992) Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules. European journal of immunology 22: 357-364.
47. Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW, (1988) Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. Journal of immunology 140: 3971-3977.
48. Savill J, Dransfield I, Gregory C, Haslett C, (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nature reviews Immunology 2: 965-975.
49. Bonilla WV, Frohlich A, Senn K, Kallert S, Fernandez M, et al. (2012) The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses. Science 335: 984-989.
50. Shi Y, Evans JE, Rock KL, (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
51. David CV, Craft N, (2009) Cutaneous and mucocutaneous leishmaniasis. Dermatologic therapy 22: 491-502.
52. Carvalho LP, Passos S, Bacellar O, Lessa M, Almeida RP, et al. (2007) Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite immunology 29: 251-258.
53. Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, et al. (2011) Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331: 775-778.
54. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, et al. (2005) Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proceedings of the National Academy of Sciences of the United States of America 102: 419-424.
55. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
56. Anderson CF, Oukka M, Kuchroo VJ, Sacks D, (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. The Journal of experimental medicine 204: 285-297.
57. Falcao SC, de Moura TR, Clarencio J, Brodskyn C, Barral A, et al. (2012) The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis. International journal for parasitology 42: 771-780.
58. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nature genetics 38: 500-501.
59. Spath GF, Beverley SM, (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Experimental parasitology 99: 97-103.